(Q40228551)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Cost-effectiveness analysis of genetic screening for the Taq1B polymorphism in the secondary prevention of coronary heart disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Linda K Kemp

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Christopher M Doran

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Pharmacoeconomics & Outcomes Research

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

119-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapy

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Economics of drug treatment: for which patients is it costeffective to lower cholesterol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

A generic model for the assessment of disease epidemiology: the computational basis of DisMod II

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Discontinuation rates for use of statins are high

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.7.2.119

21 January 2018

Identifiers

DOI

10.1586/14737167.7.2.119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20528438%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference